SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Gold/Mining/Energy : Gensci Regeneration Sciences Inc. (GNS)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Andras who wrote (215)1/12/2000 12:49:00 AM
From: twentyfirstcenturyfox  Read Replies (1) of 225
 
Thanks for that - i got it previously from gerry wimmer.
Anyway, a couple of thoughts:
The NR also mentions that 12 month revenues for fiscal Dec 31 1999 will approximate Can$30 mill. versus 16mill for 1998.
i have pushed a few numbers and this is what I get:
1999 (Mill) 1998 (Mill)
Q1 + Q2 revenues $13.9 $5.64
Q3 8.153 5.023
Q4 (my/Dr Tee's est) 7.947 5.337
12 mo. total est revenues 30.00 16.000
try to ignore the decimal numbers.
So, first point is, Q4 looks like good growth, altho' at a slower pace than earlier in the year.
second point is, in which division and at what gross margin do these sales occur? this is a question, actually.
I would expect that margins will improve in 2000, but I dont know what to expect for Q4 of 1999.
What i would also like to see - and i will be writing the new Prez re this - is fully segmented operating results to be reported in all future quarterly NR's. By that I mean, revenues, cost of sales and gross margins for each of the Bioimplant and Biopharms divisions.

why it went up and down so fast, i dunno. I just missed getting a sale at $1.70. Ah well !!
Comments? Don.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext